The findings align with the PROLONG registry and bolster evidence for limiting the duration of antithrombotic therapy.

The largest ethnic minority in the US faces earlier disease onset along with access issues and misconceptions about ...

Lead author Amar Rai, MBBS (University of Pennsylvania, Philadelphia, and Imperial College London, England), said that as a clinician working with patients who have high bleeding risks in general, he ...

MACE risk appeared to be higher in cases for which there was disagreement, perhaps identifying the need for a closer look.

Virtual reality calms claustrophobia, tweaking trial recruitment, multidisciplinary TAVI recovery efforts, and more.

The data support the scalability of the strategy—still, an editorial urges that ethical concerns among the public can’t be ...

The US Food and Drug Administration has approved the Selution SLR sirolimus-eluting balloon for the treatment of coronary ...

Leaders call for removal of this outdated metric, which they say has no bearing over ongoing interventional cardiologist ...

Office-based CCTA may be a tool cardiologists practicing in rural areas can use to identify at-risk patients earlier.

Over the last 25 years, there have been low rates of device failures and death in patients who received an ICD.

Premature heart disease in men and women in this population stands out in a way that it doesn’t in other ethnic groups.

TCTMD's Todd Neale spoke with Warraich about the ADVOCATE program, which has its sights set on heart failure first.